(Q38002002)

26 August 2017

Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities (English)

1 reference

26 August 2017

0 references

0 references

3

1 reference

26 August 2017

30

1 reference

26 August 2017

Timothy D McHugh

5

0 references

Alexandre Harari

Alexandre Harari

23

0 references

Justin O'Grady

Justin O'Grady

26

0 references

Helen Cox

Helen Cox

19

0 references

Markus Maeurer

Markus Maeurer

2

0 references

Matthew Bates

Matthew Bates

24

0 references

Ruth McNerney

Ruth McNerney

1

0 references

Martin Peter Grobusch

9

Martin P Grobusch

1 reference

26 August 2017

S Bertel Squire

11

0 references

Rifat Atun

29

Rifat Atun

1 reference

26 August 2017

20

Soumya Swaminathan

1 reference

26 August 2017

16

Peter Mwaba

1 reference

26 August 2017

18

Michael Hoelscher

1 reference

26 August 2017

10

Ziad Memish

1 reference

26 August 2017

17

Lynn Zijenah

1 reference

26 August 2017

12

Giuseppe Pantaleo

1 reference

26 August 2017

6

Nathan Ford

1 reference

26 August 2017

27

Michel Pletschette

1 reference

26 August 2017

22

Marco Schito

1 reference

26 August 2017

Jeremiah Muhwa Chakaya

13

Jeremiah Chakaya

1 reference

26 August 2017

Ben Marais

4

1 reference

26 August 2017

Karin Weyer

7

1 reference

26 August 2017

Steve Lawn

8

1 reference

26 August 2017

Martina Casenghi

14

1 reference

26 August 2017

Giovanni-Batista Migliori

15

1 reference

26 August 2017

Peter S Kim

21

1 reference

26 August 2017

Samana Schwank

25

1 reference

26 August 2017

Lucica Ditui

28

1 reference

26 August 2017

language of work or name

English

0 references

publication date

10 April 2012

1 reference

Journal of Infectious Diseases

26 August 2017

1 reference

26 August 2017

205 Suppl 2

1 reference

26 August 2017

S147-58

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

26 August 2017

1 reference

Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

A systematic review of delay in the diagnosis and treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

The urgent need for new diagnostics for symptomatic tuberculosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Viewpoint TB diagnostics: what does the world really need?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Barriers to accessing TB diagnosis for rural-to-urban migrants with chronic cough in Chongqing, China: a mixed methods study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

How affordable are tuberculosis diagnosis and treatment in rural China? An analysis from community and tuberculosis patient perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Can Malawi's poor afford free tuberculosis services? Patient and household costs associated with a tuberculosis diagnosis in Lilongwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Reducing the global burden of tuberculosis: the contribution of improved diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Making innovations accessible to the poor through implementation research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Immunological biomarkers of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

New diagnostics for tuberculosis: fulfilling patient needs first.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Infectious diseases biobanking as a catalyst towards personalized medicine: Mycobacterium tuberculosis paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

LED fluorescence microscopy for the diagnosis of pulmonary tuberculosis: a multi-country cross-sectional evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

A multi-country non-inferiority cluster randomized trial of frontloaded smear microscopy for the diagnosis of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Interferon- release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Human leukocyte antigens A*3001 and A*3002 show distinct peptide-binding patterns of the Mycobacterium tuberculosis protein TB10.4: consequences for immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Longitudinal analysis of Mycobacterium tuberculosis 19-kDa antigen-specific T cells in patients with pulmonary tuberculosis: association with disease activity and cross-reactivity to a peptide from HIVenv gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Rapid molecular detection of tuberculosis and rifampin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Evaluation of the analytical performance of the Xpert MTB/RIF assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Comparison of the Xpert MTB/RIF test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Xpert MTB/RIF test for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

La cuerda dulce--a tolerability and acceptability study of a novel approach to specimen collection for diagnosis of paediatric pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Improved recovery of Mycobacterium tuberculosis from children using the microscopic observation drug susceptibility method

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

A refined symptom-based approach to diagnose pulmonary tuberculosis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

New approaches and emerging technologies in the diagnosis of childhood tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

HIV-associated tuberculous meningitis--diagnostic and therapeutic challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplification methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Microscopic-observation drug-susceptibility assay for the diagnosis of TB

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Dynamic antibody responses to the Mycobacterium tuberculosis proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

Towards a point-of-care test for active tuberculosis: obstacles and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR860

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIR860

1 reference

26 August 2017

1 reference